Incyte (INCY) Gross Margin (2012 - 2026)
Incyte (INCY) recorded Gross Margin of 93.02% in Q3 2026, up 0.26 percentage points from 92.75% a year earlier but down 0.71 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Gross Margin (2012 - 2026) Analysis & Trends
On a TTM basis, Incyte's Gross Margin came in at 92.69% as of Sep 30, 2026, down 0.26 percentage points year-over-year; for FY2025, it came in at 92.76%, up 0.12 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -2.31 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 92.64% in FY2024 (-0.46 pp), 93.10% in FY2023 (-0.80 pp), 93.90% in FY2022 (-1.04 pp) and 94.94% in FY2021 (-0.13 pp).
- Quarterly Gross Margin has ranged from 91.79% in Q1 2026 to 94.92% in Q4 2021 over the past five years.
- On a year-over-year basis, Gross Margin rose in four of the last eight quarters, with an average year-over-year change of -0.10 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 0.86 percentage points in Q2 2025, against a drop of 1.73 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 93.73% (Q2 2026), 91.79% (Q1 2026) and 91.96% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 93.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 93.02% |
| Jun 30, 2026 | 93.73% |
| Mar 31, 2026 | 91.79% |
| Dec 31, 2025 | 91.96% |
| Sep 30, 2025 | 92.75% |
| Jun 30, 2025 | 93.52% |
| Mar 31, 2025 | 93.05% |
| Dec 31, 2024 | 92.49% |
| Sep 30, 2024 | 92.44% |
| Jun 30, 2024 | 92.66% |
| Mar 31, 2024 | 93.08% |
| Dec 31, 2023 | 93.12% |
| Sep 30, 2023 | 93.46% |
| Jun 30, 2023 | 92.84% |
| Mar 31, 2023 | 92.97% |
| Dec 31, 2022 | 93.62% |
| Sep 30, 2022 | 93.37% |
| Jun 30, 2022 | 94.44% |
| Mar 31, 2022 | 94.19% |
| Dec 31, 2021 | 94.92% |
API Access
Incyte Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();